Sjögren's syndrome pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 6: Line 6:


==Overview==
==Overview==
ُ[[Sjögren's syndrome]] is a chronic [[Autoimmune disease|auto-immune]] disorder that can affect several organ systems. Both genetic and immune factors contribute to the [[pathogenesis]] of the disease.  [[Lymphocyte|Lymphocytes]] (primarily CD4+ T-cells) infiltrate the [[lacrimal]] and [[Salivary gland|salivary]] glands and impair their function, hence causing the main characteristic [[Symptom|symptoms]] of the disease- dry mouth ([[keratoconjunctivitis sicca]]) and eyes ([[xerostomia]]).   
ُ[[Sjögren's syndrome]] is a chronic [[Autoimmune disease|auto-immune]] disorder that can affect several organ systems. Both genetic and immune factors contribute to the [[pathogenesis]] of the disease.  [[Lymphocyte|Lymphocytes]] infiltrate the [[lacrimal]] and [[Salivary gland|salivary]] glands and impair their function, hence causing the main characteristic [[Symptom|symptoms]] of the disease- dry mouth ([[keratoconjunctivitis sicca]]) and eyes ([[xerostomia]]). [[CD4|CD4+]] [[T cell|T-cells]] are predominant in mild and moderate salivary gland infiltrations, while [[B cell|B cells]] play the major role in severe lesions <ref name="pmid19889514">{{cite journal| author=Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM| title=Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome. | journal=J Autoimmun | year= 2010 | volume= 34 | issue= 4 | pages= 400-7 | pmid=19889514 | doi=10.1016/j.jaut.2009.10.004 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19889514 }}</ref>.   


==Pathophysiology==
==Pathophysiology==
The [[pathogenesis]] of [[Sjögren's syndrome]] can be linked to both genetic and nongenetic components <ref name="pmid23846338">{{cite journal| author=Mavragani CP, Nezos A, Moutsopoulos HM| title=New advances in the classification, pathogenesis and treatment of Sjogren's syndrome. | journal=Curr Opin Rheumatol | year= 2013 | volume= 25 | issue= 5 | pages= 623-9 | pmid=23846338 | doi=10.1097/BOR.0b013e328363eaa5 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23846338  }} </ref>.  
The [[pathogenesis]] of [[Sjögren's syndrome]] can be linked to both genetic and nongenetic components <ref name="pmid23846338">{{cite journal| author=Mavragani CP, Nezos A, Moutsopoulos HM| title=New advances in the classification, pathogenesis and treatment of Sjogren's syndrome. | journal=Curr Opin Rheumatol | year= 2013 | volume= 25 | issue= 5 | pages= 623-9 | pmid=23846338 | doi=10.1097/BOR.0b013e328363eaa5 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23846338  }} </ref>.  
* '''Genetic components:'''
* '''Genetic components:'''
Evidence suggests genes that encode [[Major histocompatibility complex|Major Histocompatibility Complex]] (MHC), particularly [[Human leukocyte antigen|HLA]] genes, play an important role in the disease.
Although multiple genes are found to be associated with ُ[[Sjögren's syndrome]], evidence suggests genes that encode [[Major histocompatibility complex|Major Histocompatibility Complex]] (MHC), particularly [[Human leukocyte antigen|HLA]] genes, play an important role in the disease.  
* '''Immune-mediated components:'''   


==References==
==References==

Revision as of 18:02, 28 January 2018

Sjögren's syndrome Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Sjögren's syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sjögren's syndrome pathophysiology On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sjögren's syndrome pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sjögren's syndrome pathophysiology

CDC on Sjögren's syndrome pathophysiology

Sjögren's syndrome pathophysiology in the news

Blogs on Sjögren's syndrome pathophysiology

Directions to Hospitals Treating Sjögren's syndrome

Risk calculators and risk factors for Sjögren's syndrome pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farbod Zahedi Tajrishi, M.D.

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

ُSjögren's syndrome is a chronic auto-immune disorder that can affect several organ systems. Both genetic and immune factors contribute to the pathogenesis of the disease. Lymphocytes infiltrate the lacrimal and salivary glands and impair their function, hence causing the main characteristic symptoms of the disease- dry mouth (keratoconjunctivitis sicca) and eyes (xerostomia). CD4+ T-cells are predominant in mild and moderate salivary gland infiltrations, while B cells play the major role in severe lesions [1].

Pathophysiology

The pathogenesis of Sjögren's syndrome can be linked to both genetic and nongenetic components [2].

  • Genetic components:

Although multiple genes are found to be associated with ُSjögren's syndrome, evidence suggests genes that encode Major Histocompatibility Complex (MHC), particularly HLA genes, play an important role in the disease.

  • Immune-mediated components:

References

  1. Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM (2010). "Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome". J Autoimmun. 34 (4): 400–7. doi:10.1016/j.jaut.2009.10.004. PMID 19889514.
  2. Mavragani CP, Nezos A, Moutsopoulos HM (2013). "New advances in the classification, pathogenesis and treatment of Sjogren's syndrome". Curr Opin Rheumatol. 25 (5): 623–9. doi:10.1097/BOR.0b013e328363eaa5. PMID 23846338.

Template:WS Template:WH